Page last updated: 2024-11-03

risperidone and Accessory Atrioventricular Bundle

risperidone has been researched along with Accessory Atrioventricular Bundle in 1 studies

Risperidone: A selective blocker of DOPAMINE D2 RECEPTORS and SEROTONIN 5-HT2 RECEPTORS that acts as an atypical antipsychotic agent. It has been shown to improve both positive and negative symptoms in the treatment of SCHIZOPHRENIA.
risperidone : A member of the class of pyridopyrimidines that is 2-methyl-6,7,8,9-tetrahydropyrido[1,2-a]pyrimidin-4-one carrying an additional 2-[4-(6-fluoro-1,2-benzoxazol-3-yl)piperidin-1-yl]ethyl group at position 2.

Accessory Atrioventricular Bundle: Extra impulse-conducting tissue in the heart that creates abnormal impulse-conducting connections between HEART ATRIA and HEART VENTRICLES.

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's1 (100.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Imran, TF1
Niazi, OT1
Amin, R1
Mazza, V1
Klapholz, M1

Other Studies

1 other study available for risperidone and Accessory Atrioventricular Bundle

ArticleYear
Risperidone unmasking an accessory pathway.
    International journal of cardiology, 2015, Volume: 187

    Topics: Accessory Atrioventricular Bundle; Antipsychotic Agents; Atrioventricular Node; Electrocardiography;

2015